{"disease":{"id":"secondary-hypothyroidism","name":"secondary hypothyroidism"},"drugs":{"marketed":[{"drug_id":"levoxyl","indication_name":"Secondary hypothyroidism - replacement therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levoxyl","generic_name":"Levothyroxine Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Thyroid receptor proteins attached to DNA","drug_class":"Thyroid hormone replacement","quality_score":10,"revenue":null,"mechanism":"Levothyroxine binds thyroid receptors in cell nuclei to activate gene transcription and protein synthesis."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05276856","title":"Recovery Rate in Secondary Hypothyroidism","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Nova Scotia Health Authority","has_results":false},{"nct_id":"NCT04767763","title":"Thyroid Function in Critically Ill Patients With Acute Kidney Injury","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Medical University of Gdansk","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}